Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Wyeth

Status and phase: Completed; Phase 2

Conditions: Postmenopausal Osteoporosis

Treatments: Drug: Placebo; Drug: Bazedoxifene

Study type: Interventional

Funder types: Industry

Identifiers

NCT00238745

3068A1-207

Details and patient eligibility

About

Dose-response in Japanese patients with postmenopausal osteoporosis.

Sex: Female

Ages: Under 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must be postmenopausal and diagnosed as osteoporosis based on bone mineral density and/or vertebral fracture.

Exclusion criteria

• Diseases which possibly induce secondary osteoporosis or osteopenia and affect on bone metabolism.